These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3223334)

  • 41. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
    Baron JB; Morel P; Rivoallan Y; Soulairac A
    Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496
    [No Abstract]   [Full Text] [Related]  

  • 43. Photoprotection of skin against ultraviolet A damage.
    Schaefer H; Chardon A; Moyal D
    Methods Enzymol; 2000; 319():445-65. PubMed ID: 10907533
    [No Abstract]   [Full Text] [Related]  

  • 44. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 45. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.
    Shopsin B; Gershon S; Thompson H; Collins P
    Arch Gen Psychiatry; 1975 Jan; 32(1):34-42. PubMed ID: 1089401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microprobe analysis of chlorpromazine pigmentation.
    Benning TL; McCormack KM; Ingram P; Kaplan DL; Shelburne JD
    Arch Dermatol; 1988 Oct; 124(10):1541-4. PubMed ID: 2844124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical comparison of haloperidol with chlorpromazine in mentally retarded children.
    Le Vann LJ
    Am J Ment Defic; 1971 May; 75(6):719-23. PubMed ID: 4932179
    [No Abstract]   [Full Text] [Related]  

  • 48. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 49. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
    Baron JB; Rivoalan Y; Morel P
    Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
    [No Abstract]   [Full Text] [Related]  

  • 50. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
    Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
    Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
    [No Abstract]   [Full Text] [Related]  

  • 52. Skin and eye changes associated with chlorpromazine therapy.
    Barnes GJ; Cameron ME
    Med J Aust; 1966 Mar; 1(12):478-81. PubMed ID: 5930727
    [No Abstract]   [Full Text] [Related]  

  • 53. Integrated EEG. variability: drug effects in acute schizophrenics.
    Marjerrison G; Keogh RP
    Can Psychiatr Assoc J; 1969 Aug; 14(4):403-5. PubMed ID: 4897659
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
    Almazov BN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1397-1401. PubMed ID: 4423309
    [No Abstract]   [Full Text] [Related]  

  • 55. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 56. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A case of skin pigmentation from the long-term use of kordaron].
    Zadionchenko VS; Beliakova TI; Arzhaev VI
    Klin Med (Mosk); 1988 Mar; 66(3):126. PubMed ID: 3392912
    [No Abstract]   [Full Text] [Related]  

  • 60. [Skin pigmentation caused by amiodarone].
    Casillas Ruíz JA; Fernández Berridi D; Malpartida de Torres F; Quintanilla Gutiérrez E
    Rev Esp Cardiol; 1978; 31(6):617-23. PubMed ID: 746217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.